Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-01 Sale | 2022-03-02 7:59 pm | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer | 10,000 | $36.76 | $367,570 | 85,123 (Direct) | View |
| 2021-06-08 Sale | 2021-06-10 5:35 pm | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 7,927 | $20 | $158,540 | 95,123 (Direct) | View |
| 2021-05-24 Sale(A) | 2021-06-03 4:19 pm | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 7,927 | $21.92 | $173,796 | 110,977 (Direct) | View |
| 2021-06-01 Sale | 2021-06-03 4:17 pm | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 7,927 | $20.17 | $159,903 | 206,423 (Direct) | View |
| 2021-05-24 Sale | 2021-05-26 4:09 pm | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 7,927 | $21.92 | $173,796 | 110,977 (Direct) | View |
| 2021-05-17 Sale | 2021-05-19 4:14 pm | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 7,926 | $24.69 | $195,719 | 118,904 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-07 Option Award | 2024-03-08 7:58 pm | N/A 2034-03-07 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer | 153,600 | $0 | 153,600 (Direct) | View |
| 2023-12-05 Option Award | 2023-12-07 8:22 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer | 31,000 | $0 | 31,000 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-10 7:54 pm | N/A 2033-03-09 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer | 130,000 | $0 | 130,000 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-14 8:02 pm | N/A 2032-03-11 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer | 85,000 | $0 | 85,000 (Direct) | View |
| 2022-03-01 Exercise | 2022-03-02 7:59 pm | N/A 2030-05-01 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer | 10,000 | $0 | 85,123 (Direct) | View |
| 2022-03-01 Exercise | 2022-03-02 7:59 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne Chief Scientific Officer | 10,000 | $4.24 | 85,123 (Direct) | View |
| 2021-06-08 Exercise | 2021-06-10 5:35 pm | N/A 2030-05-01 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 7,927 | $0 | 95,123 (Direct) | View |
| 2021-06-08 Exercise | 2021-06-10 5:35 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 7,927 | $4.23 | 95,123 (Direct) | View |
| 2021-05-24 Exercise(A) | 2021-06-03 4:19 pm | N/A 2030-05-01 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 7,927 | $0 | 110,977 (Direct) | View |
| 2021-05-24 Exercise(A) | 2021-06-03 4:19 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 7,927 | $4.23 | 110,977 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-03 4:17 pm | N/A 2030-05-01 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 7,927 | $0 | 206,423 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-03 4:17 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 7,927 | $4.23 | 206,423 (Direct) | View |
| 2021-05-24 Exercise | 2021-05-26 4:09 pm | N/A 2030-05-01 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 7,927 | $0 | 110,977 (Direct) | View |
| 2021-05-24 Exercise | 2021-05-26 4:09 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 7,927 | $4.23 | 110,977 (Direct) | View |
| 2021-05-17 Exercise | 2021-05-19 4:14 pm | N/A 2030-05-01 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 7,926 | $0 | 118,904 (Direct) | View |
| 2021-05-17 Exercise | 2021-05-19 4:14 pm | N/A N/A | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 7,926 | $4.23 | 118,904 (Direct) | View |
| 2021-03-01 Option Award | 2021-03-03 4:15 pm | N/A 2031-03-01 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 45,000 | $0 | 45,000 (Direct) | View |
Ownership | 2020-07-23 7:24 pm | N/A 2030-05-01 | iTeos Therapeutics Inc. | ITOS | McGrath Yvonne VP, Research and Development | 0 | $0 | 126,830 (Direct) | View |